BMJ Group Logo

GLP-1 and SGLT-2 diabetes drugs may help slow kidney damage

But little evidence of benefit seen among people without albuminuria The diabetes drugs glucagon-like peptide-1 (GLP-1) receptor agonists and sodium glucose cotransporter 2 (SGLT-2) inhibitor drugs may also help to slow decline in kidney function in people with type 2 diabetes and albuminuria (high protein levels in the urine), ...

2026-09-16T15:28:04+01:0017 September 2026|Press release, The BMJ|

Third of UK government’s nutrition advisors still paid by food companies including Coca Cola and Nestlé

Financial conflicts of interest still rife, despite new rules banning such links Public health experts say conflicts should be removed ‘immediately’ Nearly a third of the government’s nutrition advisors still have “significant” ties to the food industry including Coca Cola, Sainsbury’s, and Danone, reveals a new analysis by The ...

2026-09-10T09:36:59+01:0010 September 2026|Press release, The BMJ|

Eminent cardiologist involved in treatment guidelines received £50m from drug research contracts

Eminent cardiologist involved in treatment guidelines received £50m from drug research contracts Case shows what’s at stake in the debate around transparency of doctor-industry relations A British cardiologist and former president of the European Society of Cardiology (ESC) has been judged by the ESC to have committed severe misconduct ...

2026-09-02T09:27:51+01:0027 August 2026|Press release, The BMJ|

At least 1 in 4 former NFL players who died during 2016-21 had evidence of brain disease at death linked to repeated head impacts

New estimates strengthen evidence of confirmed CTE burden in former NFL players, while highlighting uncertainties   At minimum, nearly a quarter of all former National Football League (NFL) players who died from 2016 to 2021 had confirmed chronic traumatic encephalopathy (CTE) – a neurodegenerative disease linked to repeated head impacts  – ...

2026-09-03T15:53:54+01:0025 August 2026|Press release, The BMJ|
Go to Top